Revance Therapeutics Inc (RVNC) is destined for greater heights as its last quarter sales were 59,880 K
Revance Therapeutics Inc (NASDAQ: RVNC) kicked off on Tuesday, up 5.79% from the previous trading day, before settling in for the closing price of $3.80.